News
Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...
Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback